MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
ConditionHIV/AIDS
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age16-25
SponsorColumbia University
About this trial
MyPEEPS Mobile Plus, a multi-level intervention for improving HIV prevention outcomes in YMSM, is a novel and evidence-driven approach using mobile technology to deliver HIV prevention information specifically developed for YMSM. Building on strong preliminary work, the proposed research is the next logical step in a body of work designed to assess whether refinement of this mobile intervention used in combination with virtual PrEP Peer Navigation will result in improvements in PrEP uptake and a reduction in HIV-related behavior. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
16-25 years of age
identify as male or non-binary
male sex assigned at birth
understand and read English
Disqualifiers
HIV Positive
If study staff determine participant unable to consent due to obvious and severe cognitive impairment or under the influence of drugs or alcohol
currently report consistent use of PrEP
currently enrolled in another HIV prevention study
Trial design
Design model
Parallel
Treatments tested in this trial
MyPEEPS Mobile
BehavioralAn evidence-based, digitally delivered mHealth sexual risk reduction intervention on HIV incidence
Electronic PrEP peer navigation
BehavioralElectronic peer navigation to PreP services
Treatment groups
500 Participants
are divided into 2 treatment groupsGroup A: ControlActive comparator 1 intervention
Group B: InterventionExperimental treatment 2 interventions
Trial outcomes
Primary outcomes
1
PrEP Initiation:
Participants will self-report attending at least one PrEP-related care visit to asess medical eligibility for PrEP initiation.
Time frame
Baseline, 6-month follow-up, 12-month follow-upSecondary outcomes
1
PrEP Adherence
Daily oral PrEP users will report PrEP use in the past 7-days.
Time frame
Baseline, 6-month follow-up, 12-month follow-up2
PrEP Persistence
Questions will be measure visit constancy, i.e., self-report at least 1 PrEP related care visit in the past 6 months.
Time frame
Baseline, 6-month follow-up, 12-month follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Columbia University
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
Callen-Lorde Community Health Center
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Source ClinicalTrials.gov